A Phase II Study of the Combination of Aflibercept (VEGF-Trap) plus Modified FOLFOX 6 in Patients with Previously Untreated Metastatic Colorectal Cancer
Description: 

To evaluate the progression free survival (PFS) of patients with untreated metastatic colorectal cancer (mCRC) receiving the combination of modified FOLFOX6 (mFOLFOX6) and aflibercept.

Study Number: 

I 239813

Phase: 
II
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01652196

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.